Literature DB >> 3872758

Anti-T cell antibodies in primary glomerulonephritis.

K Nakabayashi, Y Arimura, M Yoshida, T Nagasawa.   

Abstract

Lymphocytotoxic antibodies are frequently found in systemic lupus erythematosus (SLE) and several viral infections and are presumed to play an important role in the pathogenesis of these diseases through the modulation of lymphocyte subsets. Accordingly, using a slightly modified E rosette inhibition test, we investigated anti-T cell antibodies in lupus nephritis and various forms of primary glomerulonephritis to determine the correlation with lymphocyte subsets, macrophages and serum immune complexes. Patients with active lupus nephritis showed the highest titers and incidences of anti-T cell antibodies. Titers and incidences in primary glomerulonephritis were less than in lupus nephritis. Among the various forms of glomerulonephritis, the titers and incidences were greatest in membrano-proliferative glomerulonephritis and minimal change nephrotic syndrome, next in membranous glomerulonephritis, and least in IgA glomerulonephritis. The antibodies were positive in the stages of nephrotic syndrome or macrohematuria of these diseases. If detected, antibodies were associated with decreased T and T gamma cells, increased numbers of macrophages and elevated serum immune complexes. These data suggest that anti-T cell antibodies are cytotoxic to T and T gamma lymphocytes and modulate the immunological network, thus playing an important role in the pathogenesis of various forms of glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3872758

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  2 in total

Review 1.  Lymphocytotoxic antibodies in SLE: a review of the literature.

Authors:  C Osman; A J Swaak
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

2.  [Frequency, clinical implication and prognostic value of lymphopenia in systemic lupus erythematosus: case-control study].

Authors:  Fatima Zahra Ha-ou-nou; Lamiaa Essaadouni
Journal:  Pan Afr Med J       Date:  2015-05-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.